photo
Speaker

Peter Moriarty

CHAIRMAN, CORPORATE DEVELOPMENT ADVISORY BOARD, NEUROEM THERAPEUTICS, INC.
Scottsdale, Arizona, United States
Peter Moriarty – has extensive experience in the pharmaceutical and healthcare industries both in the United States and internationally. He was a co-founder of Shire Pharmaceuticals, an international specialty pharmaceutical company acquired by Takeda Pharmaceuticals (TAK: NASDAQ). Peter was also the co-founder, Chairman and Chief Executive Officer of Prismic Pharmaceuticals, a specialty pharmaceutical company acquired by FSD Pharma (HUGE: NASDAQ) in 2019. Peter’s earlier career spanned management positions within Warner-Lambert/ Parke-Davis and Schering-Plough, including leadership positions overseas as well as in the United States.
Speaking In
11:30 AM - 11:45 AM (PDT)
Tuesday, June 14
NeuroEM is a clinical-stage company that has received FDA "Breakthrough" designation for its…